Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-Μg or 50-Μg Daily Doses

Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2017.08.011

Related search